Soon after the discovery that NOD2 makes an unusually large contribution to Crohn’s disease risk in Europeans, potential clinical utility in prediction of fibrostenotic disease progression or need for surgery was considered [19, 20]. The gene discussed is NOD2; the disease is Crohn disease.